Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Factor in A Rabbit Model

Shigeru Hirano, Diane M. Bless, Bernard Rousseau, Nathan Welham, Douglas Montequin, Roger W. Chan, Charles N. Ford

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Objectives/Hypothesis: Vocal fold scarring disrupts the layer structure of the vocal fold lamina propria that is essential for optimal mucosal vibration. Prevention of vocal fold scarring remains challenging. Hepatocyte growth factor (HGF) has strong antifibrotic activity. The authors' previous studies have found that HGF stimulates hyaluronic acid production and suppresses collagen production from vocal fold fibroblasts, suggesting that HGF has therapeutic potential in prevention of vocal fold scarring. The present study aimed to demonstrate the effects of HGF on vocal fold scarring in an in vivo rabbit model. Study Design: Animal experiment. Methods: The vocal fold mucosa was stripped unilaterally in 20 rabbits, then HGF or saline (sham-treated group) was immediately injected into the injured site. At 6 months after the procedure, histological, rheological, and physiological examinations of vibratory behavior were completed. Results: Histological examination revealed excessive collagen deposition and disorganized elastin in the sham-treated group, whereas the HGF-treated group presented with better wound healing exhibiting less collagen deposition. Contraction of the injured vocal folds observed in the sham-treated group did not occur in the HGF-treated group. Rheological data indicated that the HGF-treated vocal folds were less stiff and viscous compared with the sham-treated group. Mucosal vibration of HGF-treated vocal folds appeared much better than the sham-treated group in terms of phonation threshold pressure, vocal efficiency, mucosal wave amplitude, and glottal closure. Conclusion: Hepatocyte growth factor proved to be useful in preventing vocal fold scarring and maintaining viscoelastic shear properties of the vocal fold.

Original languageEnglish (US)
Pages (from-to)548-556
Number of pages9
JournalLaryngoscope
Volume114
Issue number3
DOIs
StatePublished - Mar 2004

Fingerprint

Vocal Cords
Hepatocyte Growth Factor
Cicatrix
Hepatocytes
Rabbits
Injections
Collagen
Vibration
Mucous Membrane
Phonation
Elastin
Hyaluronic Acid
Wound Healing
Fibroblasts

Keywords

  • Hepatocyte growth factor
  • Histology
  • Rabbit model
  • Rheology
  • Vocal fold scarring
  • Vocal fold vibration

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Factor in A Rabbit Model. / Hirano, Shigeru; Bless, Diane M.; Rousseau, Bernard; Welham, Nathan; Montequin, Douglas; Chan, Roger W.; Ford, Charles N.

In: Laryngoscope, Vol. 114, No. 3, 03.2004, p. 548-556.

Research output: Contribution to journalArticle

Hirano, S, Bless, DM, Rousseau, B, Welham, N, Montequin, D, Chan, RW & Ford, CN 2004, 'Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Factor in A Rabbit Model', Laryngoscope, vol. 114, no. 3, pp. 548-556. https://doi.org/10.1097/00005537-200403000-00030
Hirano, Shigeru ; Bless, Diane M. ; Rousseau, Bernard ; Welham, Nathan ; Montequin, Douglas ; Chan, Roger W. ; Ford, Charles N. / Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Factor in A Rabbit Model. In: Laryngoscope. 2004 ; Vol. 114, No. 3. pp. 548-556.
@article{3c6444eb6d84426daf2f06263f96c4be,
title = "Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Factor in A Rabbit Model",
abstract = "Objectives/Hypothesis: Vocal fold scarring disrupts the layer structure of the vocal fold lamina propria that is essential for optimal mucosal vibration. Prevention of vocal fold scarring remains challenging. Hepatocyte growth factor (HGF) has strong antifibrotic activity. The authors' previous studies have found that HGF stimulates hyaluronic acid production and suppresses collagen production from vocal fold fibroblasts, suggesting that HGF has therapeutic potential in prevention of vocal fold scarring. The present study aimed to demonstrate the effects of HGF on vocal fold scarring in an in vivo rabbit model. Study Design: Animal experiment. Methods: The vocal fold mucosa was stripped unilaterally in 20 rabbits, then HGF or saline (sham-treated group) was immediately injected into the injured site. At 6 months after the procedure, histological, rheological, and physiological examinations of vibratory behavior were completed. Results: Histological examination revealed excessive collagen deposition and disorganized elastin in the sham-treated group, whereas the HGF-treated group presented with better wound healing exhibiting less collagen deposition. Contraction of the injured vocal folds observed in the sham-treated group did not occur in the HGF-treated group. Rheological data indicated that the HGF-treated vocal folds were less stiff and viscous compared with the sham-treated group. Mucosal vibration of HGF-treated vocal folds appeared much better than the sham-treated group in terms of phonation threshold pressure, vocal efficiency, mucosal wave amplitude, and glottal closure. Conclusion: Hepatocyte growth factor proved to be useful in preventing vocal fold scarring and maintaining viscoelastic shear properties of the vocal fold.",
keywords = "Hepatocyte growth factor, Histology, Rabbit model, Rheology, Vocal fold scarring, Vocal fold vibration",
author = "Shigeru Hirano and Bless, {Diane M.} and Bernard Rousseau and Nathan Welham and Douglas Montequin and Chan, {Roger W.} and Ford, {Charles N.}",
year = "2004",
month = "3",
doi = "10.1097/00005537-200403000-00030",
language = "English (US)",
volume = "114",
pages = "548--556",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Prevention of Vocal Fold Scarring by Topical Injection of Hepatocyte Factor in A Rabbit Model

AU - Hirano, Shigeru

AU - Bless, Diane M.

AU - Rousseau, Bernard

AU - Welham, Nathan

AU - Montequin, Douglas

AU - Chan, Roger W.

AU - Ford, Charles N.

PY - 2004/3

Y1 - 2004/3

N2 - Objectives/Hypothesis: Vocal fold scarring disrupts the layer structure of the vocal fold lamina propria that is essential for optimal mucosal vibration. Prevention of vocal fold scarring remains challenging. Hepatocyte growth factor (HGF) has strong antifibrotic activity. The authors' previous studies have found that HGF stimulates hyaluronic acid production and suppresses collagen production from vocal fold fibroblasts, suggesting that HGF has therapeutic potential in prevention of vocal fold scarring. The present study aimed to demonstrate the effects of HGF on vocal fold scarring in an in vivo rabbit model. Study Design: Animal experiment. Methods: The vocal fold mucosa was stripped unilaterally in 20 rabbits, then HGF or saline (sham-treated group) was immediately injected into the injured site. At 6 months after the procedure, histological, rheological, and physiological examinations of vibratory behavior were completed. Results: Histological examination revealed excessive collagen deposition and disorganized elastin in the sham-treated group, whereas the HGF-treated group presented with better wound healing exhibiting less collagen deposition. Contraction of the injured vocal folds observed in the sham-treated group did not occur in the HGF-treated group. Rheological data indicated that the HGF-treated vocal folds were less stiff and viscous compared with the sham-treated group. Mucosal vibration of HGF-treated vocal folds appeared much better than the sham-treated group in terms of phonation threshold pressure, vocal efficiency, mucosal wave amplitude, and glottal closure. Conclusion: Hepatocyte growth factor proved to be useful in preventing vocal fold scarring and maintaining viscoelastic shear properties of the vocal fold.

AB - Objectives/Hypothesis: Vocal fold scarring disrupts the layer structure of the vocal fold lamina propria that is essential for optimal mucosal vibration. Prevention of vocal fold scarring remains challenging. Hepatocyte growth factor (HGF) has strong antifibrotic activity. The authors' previous studies have found that HGF stimulates hyaluronic acid production and suppresses collagen production from vocal fold fibroblasts, suggesting that HGF has therapeutic potential in prevention of vocal fold scarring. The present study aimed to demonstrate the effects of HGF on vocal fold scarring in an in vivo rabbit model. Study Design: Animal experiment. Methods: The vocal fold mucosa was stripped unilaterally in 20 rabbits, then HGF or saline (sham-treated group) was immediately injected into the injured site. At 6 months after the procedure, histological, rheological, and physiological examinations of vibratory behavior were completed. Results: Histological examination revealed excessive collagen deposition and disorganized elastin in the sham-treated group, whereas the HGF-treated group presented with better wound healing exhibiting less collagen deposition. Contraction of the injured vocal folds observed in the sham-treated group did not occur in the HGF-treated group. Rheological data indicated that the HGF-treated vocal folds were less stiff and viscous compared with the sham-treated group. Mucosal vibration of HGF-treated vocal folds appeared much better than the sham-treated group in terms of phonation threshold pressure, vocal efficiency, mucosal wave amplitude, and glottal closure. Conclusion: Hepatocyte growth factor proved to be useful in preventing vocal fold scarring and maintaining viscoelastic shear properties of the vocal fold.

KW - Hepatocyte growth factor

KW - Histology

KW - Rabbit model

KW - Rheology

KW - Vocal fold scarring

KW - Vocal fold vibration

UR - http://www.scopus.com/inward/record.url?scp=1642417915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642417915&partnerID=8YFLogxK

U2 - 10.1097/00005537-200403000-00030

DO - 10.1097/00005537-200403000-00030

M3 - Article

C2 - 15091233

AN - SCOPUS:1642417915

VL - 114

SP - 548

EP - 556

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 3

ER -